Complement factor B targeting small interfering RNA (Argo Biopharma)

N/A

Report date: 2024/03/05 14:42:35
NME

Base Information

Drug NameComplement factor B targeting small interfering RNA (Argo Biopharma)
Drug Alias NameCFB siRNA (Argo Biopharma)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionComplement factor B modulators
TargetsComplement factor B
Therapy Area/IndicationsHemoglobinuria, ParoxysmalGlomerulonephritis, IGAMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Argo Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Argo Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemoglobinuria, ParoxysmalGlomerulonephritis, IGAMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A